Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari "Aldo Moro", Bari, Italy,
Department of Clinical Research in Neurology, Center for Neurodegenerative Diseases and the Aging Brain, University of Bari "Aldo Moro", "Pia Fondazione Cardinale G. Panico", Tricase, Italy,
Neuroepidemiology. 2019;52(1-2):93-103. doi: 10.1159/000493386. Epub 2019 Jan 2.
Amyotrophic lateral sclerosis (ALS) epidemiology has rapidly developed in the last 30 years alongside the evolving changes in concepts in the field of clinical ALS and also due to the recent proposals of new classification system for motor neuron diseases. Many of these changes in the clinical scenario have been determined through the results of ALS population-based studies conducted in the last 20 years primarily in Europe. All the evidences converge to show that ALS risk is different across continents and ethnicities. In a European registry consortium named EURALS, ALS incident cases were drawn from a source population comprising almost 24 million people across Europe (ALS cases: 1028) and the estimated incidence was 2.2 per 100,000 person-years (py) for the general population. In contrast, other population-based studies have measured the lowest incidence in East Asia to be 0.89 per 100,000 py and in South Asia to be 0.79 per 100,000 py. A large part of Africa, Latin America and Asia does not have any population-based studies. The origin of geographic difference in ALS incidence is a matter of debate. Probably, this is partly due to genes (C9ORF72) and partly due to environmental risk factors. The rapid disappearance of ALS Foci in Guam, Kii, and West Guinea underline the importance of changes in lifestyle and environmental factors. The Global Burden of Disease, a project aiming to describe the burden of all diseases and injuries across all the countries of the world with a standardized protocol, has collected heterogeneous sources of data to estimate the burden of motor neuron diseases. The demographic changes related to increased expectation of life and the growth of the world population indicate that the load of motor neuron disease is rapidly moving toward 400 thousand prevalent cases. The burden is expected to shift toward Asia and Africa in the next decades for the rapid increase of expectation of life of countries with high demographic impact.
肌萎缩侧索硬化症(ALS)的流行病学在过去 30 年中发展迅速,这与临床 ALS 领域概念的不断变化以及运动神经元疾病新分类系统的最近建议有关。这些临床变化中的许多都是通过过去 20 年来在欧洲进行的 ALS 人群研究的结果确定的。所有这些证据都表明,ALS 的风险在各大洲和种族之间存在差异。在一个名为 EURALS 的欧洲登记处联盟中,ALS 发病病例来自一个包含欧洲近 2400 万人的源人群(ALS 病例:1028 例),估计发病率为每 10 万人 2.2 例/人年(py)。相比之下,其他人群研究表明,东亚的最低发病率为 0.89/10 万 py,南亚为 0.79/10 万 py。非洲、拉丁美洲和亚洲的很大一部分地区没有任何人群研究。ALS 发病率的地理差异的起源是一个有争议的问题。可能,这部分是由于基因(C9ORF72),部分是由于环境风险因素。关岛、纪伊和西非 ALS 病灶的迅速消失强调了生活方式和环境因素变化的重要性。全球疾病负担是一个旨在用标准化方案描述世界所有国家所有疾病和伤害负担的项目,它收集了来自不同来源的数据来估计运动神经元疾病的负担。与预期寿命增加相关的人口变化和世界人口的增长表明,运动神经元疾病的负担正在迅速增加到 40 万例。在未来几十年,预计亚洲和非洲的负担将增加,因为人口影响大的国家的预期寿命增长迅速。